These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 2013112

  • 1. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
    Sava G, Zorzet S, Perissin L, Pacor S, Lassiani L, Nisi C, Varnavas A.
    Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112
    [Abstract] [Full Text] [Related]

  • 2. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T, Sava G, Cuman R, Nisi C, Lassiani L.
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
    Giraldi T, Sava G, Mitri E, Cherubino R.
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
    [Abstract] [Full Text] [Related]

  • 8. Kinetic investigation of the aqueous stability and antitumor activity of a hydrosoluble diaryltriazene, AVIS, related to the antimetastatic agent DM-COOK.
    Lassiani L, Ebert C, Nisi C, Varnavas A, Zorzet S, Sava G, Boccù E.
    Pharmazie; 1990 Oct; 45(10):743-5. PubMed ID: 2089382
    [Abstract] [Full Text] [Related]

  • 9. Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition.
    Sava G, Pacor S, Bergamo A, Cocchietto M, Mestroni G, Alessio E.
    Chem Biol Interact; 1995 Mar 30; 95(1-2):109-26. PubMed ID: 7697744
    [Abstract] [Full Text] [Related]

  • 10. Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
    Sava G, Giraldi T, Perissin L, Zorzet S, Mallardi F, Grill V.
    Tumori; 1984 Dec 31; 70(6):477-83. PubMed ID: 6531789
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T, D'Incalci M.
    Cancer Chemother Pharmacol; 1984 Dec 31; 13(2):139-41. PubMed ID: 6467499
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
    Sava G, Giraldi T, Nisi C, Bertoli G.
    Cancer Treat Rep; 1982 Jan 31; 66(1):115-20. PubMed ID: 7053247
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of postsurgical immunotherapy with PGM in mice bearing Lewis lung carcinoma treated with p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt.
    Sava G, Zorzet S, Perissin L, Lassiani L, Tomasic J.
    Methods Find Exp Clin Pharmacol; 1985 Sep 31; 7(9):477-80. PubMed ID: 4079598
    [Abstract] [Full Text] [Related]

  • 16. Mechanism of the antileukemic effects of 1-p-carboxamidophenyl-3,3-dimethyltriazene and its in vitro metabolites.
    Sava G, Giraldi T, Lassiani L, Nisi C, Farmer PB.
    Biochem Pharmacol; 1982 Nov 15; 31(22):3629-34. PubMed ID: 7181944
    [Abstract] [Full Text] [Related]

  • 17. Effects of some ruthenium chelates on MCa mammary carcinoma and on TLX5 lymphoma in mice.
    Bregant F, Pacor S, Ghosh S, Chattopadhyay SK, Sava G.
    Anticancer Res; 1993 Nov 15; 13(4):1011-7. PubMed ID: 8352519
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCa mammary carcinoma.
    Sava G, Zorzet S, Pacor S, Mestroni G, Zassinovich G.
    Cancer Chemother Pharmacol; 1989 Nov 15; 24(5):302-6. PubMed ID: 2758559
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.